Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165691 · ClinicalTrials.gov registry record · NA
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
A NA study of Lung Neoplasms, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT07165691 is a NA study of Lung Neoplasms that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 91 participants, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07165691, a NA study of Lung Neoplasms, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer. Aim 2: Assess the feasibility, acceptability, and implementation potential of the culturally adapted TELESCOPE intervention delivered by bilingual patient navigators for Hispanics. Hypothesis 1: The investigators expect a recruitment rate of ≥60%, ≥90% of Hispanic participants will complete the 1-week follow-up assessments, ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators, and ≥90% of participants and clinicians will agree or completely agree that the intervention was feasible and acceptable. Aim 3: Explore the impact of a culturally adapted TELESCOPE intervention delivered by bilingual patient navigators vs enhanced usual care (EUC) on the initial uptake of low-dose computed tomography (LDCT) and quality of the shared decision-making (SDM) process. Hypothesis 2: The investigators expect that an adapted TELESCOPE intervention will result in higher uptake of LDCT and higher SDM quality for lung cancer screening (LCS) compared to EUC.
Conditions Studied
Interventions
- BEHAVIORAL TELESCOPE, Remote Decision Coaching with Navigation Intervention
Study Locations (1)
New Jersey
- Rutgers Cancer Institute - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07165691
The ClinicalTrials.gov registry entry for NCT07165691 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (80% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which TELESCOPE, Remote Decision Coaching with Navigation Intervention is the first listed.
NCT07165691 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07165691 about?
NCT07165691 is a clinical study titled "TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics". Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk fo...
What is the current status of trial NCT07165691?
This trial is currently recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2025-09-11. Estimated completion is 2027-06-30.
What conditions does trial NCT07165691 study?
This clinical trial studies the following conditions: Lung Neoplasms.
What interventions are being tested in trial NCT07165691?
The interventions under investigation include: TELESCOPE, Remote Decision Coaching with Navigation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07165691?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07165691 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Specimen Banking From Patients With Lung Cancer
RECRUITING
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
-
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.